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Abstract
The Mechanism of Action of the Human Microbiome (MAHMI) database is a unique
resource that provides comprehensive information about the sequence of potential
immunomodulatory and antiproliferative peptides encrypted in the proteins produced by
the human gut microbiota. Currently, MAHMI database contains over 300 hundred million
peptide entries, with detailed information about peptide sequence, sources and potential
bioactivity. The reference peptide data section is curated manually by domain experts.
The in silico peptide data section is populated automatically through the systematic
processing of publicly available exoproteomes of the human microbiome. Bioactivity pre-
diction is based on the global alignment of the automatically processed peptides with ex-
perimentally validated immunomodulatory and antiproliferative peptides, in the reference
section. MAHMI provides researchers with a comparative tool for inspecting the potential
immunomodulatory or antiproliferative bioactivity of new amino acidic sequences and
identifying promising peptides to be further investigated. Moreover, researchers are wel-
come to submit new experimental evidence on peptide bioactivity, namely, empiric and
structural data, as a proactive, expert means to keep the database updated and improve
the implemented bioactivity prediction method. Bioactive peptides identified by MAHMI
have a huge biotechnological potential, including the manipulation of aberrant immune
responses and the design of new functional ingredients/foods based on the genetic se-
quences of the human microbiome. Hopefully, the resources provided by MAHMI will be
useful to those researching gastrointestinal disorders of autoimmune and inflammatory
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nature, such as Inflammatory Bowel Diseases. MAHMI database is routinely updated and
is available free of charge.
Database URL: http://mahmi.org/
Introduction
Human beings live in a homeostatic symbiosis with their
gastrointestinal microbes (1). The host provides microbiota
with nutrients and a friendly environment, whereas the
microbiota helps in the development of the gut mucosa,
including the immune system, and provides the host with
nutritional contributions (2). Different functions have been
assigned to human gut microbiota, including maintenance
of the epithelial barrier, direct or indirect inhibition of
pathogen adhesion to intestinal surfaces, modulation and
proper maturation of the immune system, degradation of
otherwise non-digestible carbon sources (such as plant
polysaccharides), and production of different metabolites
(such as vitamins and short-chain fatty acids), among
which butyric acid is of paramount importance for colono-
cyte physiology (3). Despite of the growing number of solid
scientific evidences showing that our intestinal microbiota
is implicated in maintaining the gut physiology, we are far
from reaching a clear understanding about the molecular
mechanisms underlying this mutualism and how alter-
ations in the relative amounts of microbiota populations
are related to human health (4).
In order to maintain intestinal homeostasis, host bac-
teria and human immune system are constantly engaged in
sensing and reacting to one another by means of specific
molecules such as extracellular proteins (5). The human
gastrointestinal tract (GIT), and more concisely the gut-
associated lymphoid tissue (GALT), is perhaps the main
point of contact between gut microorganisms and the
human host. Peyer’s patches and lymphoid/plasma cells are
important GALT structures in the lower parts of the GIT,
and whereas the first have precise localizations, the second
are diffusely distributed throughout the gut mucosa (6).
Interaction between microbiota and host, also referred to
as molecular cross-talking, is elicited by a series of rela-
tively well-conserved molecules known as microbial-
associated molecular patterns (MAMPs). MAMPS interact
with specific receptors on the surface of host cells named
pattern-recognition receptors (PRRs), driving the normal
interaction occurring in a homeostatic situation and also
some of the beneficial effects attributed to probiotics (7).
The interaction of MAMPs with PRRs also affects the mat-
uration of antigen-presentation cells, which will
subsequently define the type of T-cell immune response
(mainly Th1, Th2, Th17 or Treg) (8).
Several non-infectious human diseases, including auto-
immune, inflammatory diseases and certain types of can-
cer, are related to both an immunological imbalance and a
dysbiosis of the gut microbiota (9–12). Possibly, the para-
digm of the link between gut microbiota and immunity are
the Inflammatory Bowel Diseases (IBD), in which an aber-
rant immune response to the gut microbiota is related to
development, persistence and relapse of the disease (13,
14). Indeed, faecal microbiota transplantation leads to
complete remission in about 40% of the cases, even though
there is a relative high heterogeneity among patients (15).
In this regard, some species have been found to be underre-
presented in the faecal microbiota of patients suffering
from IBD, such as the butyrate producing bacteria
Faecalibacterium praustnizii, which has been postulated
as a biomarker or even as a potential therapeutic agent
(16, 17). However, it should be taken into account that
several studies point to the involvement of genetic predis-
position due to IBD-promoting gene mutations (18, 19).
This work introduces the Mechanism of Action of the
Human Microbiome (MAHMI) database, a novel and
comprehensive resource containing peptides extracted
from the human microbiome complemented with potential
immunomodulatory or antiproliferative bioactivity.
MAHMI has two data sections: the reference data section
that contains peptides whose bioactivity has been experi-
mentally tested and the in silico data section, which keeps
peptides encrypted in larger bacterial proteins that exhibit
sequence similarity with the peptides contained in the ref-
erence data section, and which might be potentially bio-
active. Our bioactivity prediction method encompasses in
silico protein digestion using intestinal proteases from pro-
tein microbiome complements and global sequence similar-
ity search against the reference peptides.
The overall aim of MAHMI is to facilitate the work of
those scientific teams working in the field of the molecular
interaction between the human host and the intestinal
microbiota. Most notably, MAHMI Web-based interface
enables the comparison of user-submitted amino acidic se-
quences against database contents and thus, it can be
ideally used to identify peptides that may be used to ma-
nipulate altered immune responses. MAHMI has a clear
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application in the framework of IBD, but also in other
immune-associated diseases where the gut microbiota plays
a part, including Irritable Bowel Syndrome (20, 21), Celiac
Disease (22, 23) and Type-1 Diabetes (24, 25).
Database construction and update
Database overview
The system integrates a Web-based front-end, a Java appli-
cation as processing core (version 1.8.0_66) and a MySQL
data management system (version 14.14). The front-end is
a PHP application (version 5.5.9) with a Bootstrap inter-
face. The MAHMI site is best viewed by Google Chrome
46.0, Firefox 45.0.1, Opera 36.0 and Safari browsers.
Data sources: reference and in silico sections
The MAHMI database consists of two data sections
(Figure 1). The reference section (left side) is manually
annotated and reviewed, containing information extracted
from the scientific literature and other public, manually
curated databases about experimentally validated immu-
nomodulatory peptides. The in silico data section (right
side) is automatically generated and annotated based on
the computational analysis of the exoproteomes of the
human microbiome and the identification of peptides with
immunomodulatory potential.
The main sources of the reference section are scientific lit-
erature, the VaxinPAD server of peptide-based vaccine adju-
vants (26) and the CancerPPD database on antiproliferative
peptides and proteins (27). Although retrieval and annota-
tion of some of these data is automated at some extent, this
curation workflow is primarily manual. Most notably, scien-
tific literature is retrieved from the Web of Science Database
(23/05/2015) and manually curated by experts. Search starts
by using the terms ‘bioactive’ and ‘peptides’, and is further
refined using terms such as ‘antiinflammatory’, ‘anti-inflam-
matory’, ‘antiproliferative’, ‘anti-proliferative’, ‘antitumor’,
‘anti-tumor’, ‘antitumoral’, ‘apoptosis’, ‘sequence’, ‘cancer’,
‘dendritic cell’, ‘IL-10’, ‘immunomodulating’,
‘immunomodulation’, ‘immunomodulatory’, ‘macrophages’
and ‘monocytes’. The first literature retrieval rendered a
total of 1781 records. Works reporting the amino acid se-
quence of an antiproliferative or immunomodulatory pep-
tide were kept (74 records). The contents of VaxinPAD and
CancerPPD databases are automatically retrieved, but our
curators revise all new entries before insertion into MAHMI
database. Moreover, all peptide entries in MAMHI maintain
cross-links to the original sources (i.e. database identifiers
and PubMed identifiers, in the case of scientific literature).
Figure 1. Data sections and curation workflow. The curation workflow is divided into two processes: manual curation and automatic annotation.
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Complementarily, the MetaHIT project (http://www.
metahit.eu/) is the primary data source of the in silico data
section (28). Specifically, protein data downloadable via
the GigaDB FTP site (ftp://climb.genomics.cn/pub/10.5524/
100001_101000/100064/1.GeneCatalogs/). These proteins
are processed and the peptides that show immunomodula-
tory or anti-inflammatory potential are inserted in
MAHMI database. Noteworthy, this data compilation and
screening process runs in continuous mode and MAHMI
database is routinely updated on a weekly basis.
In silico bioactivity prediction
This module is implemented as a Java 8 application that uses
a REST API to communicate with the rest of the system. Our
REST API ensures the modular design of the system, such
that each component performs a specific/limited scope func-
tionality and hence, individual components may be inter-
changed as needed without affecting the rest of the system.
Notably, communication is based on the interchange of
XML and JSON objects. The data workflow is as follows.
Protein digestion
This module is responsible for the digestion of the proteins
downloaded from MetaHIT. In silico digestion is performed
using the ExPASy mzJava (http://mzjava.expasy.org) library
(29) and considering the major human intestinal endopro-
teases, i.e. trypsin, chemotrypsin and pepsin (pH< 2). The
resulting collections of peptides, denominated peptidomes,
are stored in the MySQL data repository.
Bioactivity prediction
All peptides generated by enzyme digestion are processed
to predict any possible bioactivity. The MAHMI module
responsible for this task is built on top of ClustalX, the lat-
est and more scalable version of the well-known Clustal
multiple sequence alignment tool (30). Peptides are aligned
against the peptides of the reference data section (described
in the Data Sources section).
For the first version of the database and in an attempt
to give a first bioactivity index, a peptide was considered
as potentially bioactive if its amino acid similarity with ex-
perimentally validated peptides was >60% as returned by
the ClustalX algorithm.
Query capabilities
The graphical user interface (GUI) of MAHMI database is
available at http://mahmi.org. This is a PHP application
with a dynamic and user-friendly Bootstrap interface, which
expedites the use of HTML5, CSS3 and JQuery technologies
in interface development (http://getbootstrap.com/).
Quick search
By selecting this option, the user can compare amino acidic
sequences against the two data sections of MAHMI. The
list of results is produced based on the similarity scores cal-
culated by the NCBI BLASTþ tool BLASTP alignment (31).
Advanced search
The configuration of advanced search options (Figure 2)
allows the user to select a specific data section and use
search facets, such as the bioactivity potential threshold
(i.e. predicted peptide should have a similarity equal or
greater than the specified threshold) or the bioactivity type
(i.e. immunomodulatory, antiproliferative or both). These
filters are applied over BLASTP alignment results.
Results page
MAHMI Web interface enables the graphical interpret-
ation of all alignments of the user sequence to database re-
cords. This interpretation is enabled by two visual and
interactive components: (1) a HTML object that presents
the distribution of BLAST hits on the query sequence, indi-
cating the extent and region of the alignments; (2) a table
that describes the main high-scoring pair attributes of all
the hits (32). These two visual components have been built
using BlasterJS, an in-house developed and publicly avail-
able JavaScript library for displaying BLAST results (http://
sing.ei.uvigo.es/blasterjs).
As illustrated in Figure 3, the hits distribution compo-
nent summarises all search results. The visual appearance
and interpretation of this component is similar to that of
NCBI BLAST service, which is quite familiar to most do-
main users (http://blast.ncbi.nlm.nih.gov). Exception being
that in our visual component hits coming from the refer-
ence data section will be presented first. Hits are coloured
by score (full-colour and grey-scale views are available).
By clicking on one hit, the user views the corresponding
hit in the alignment table. As illustrated in Figure 4, the
alignment hits table gathers together all BLAST hits and
their attributes: bit score, expected value (e-value), iden-
tity, positives and gaps (32). Record ordering is two-fold:
first, entries are sorted by data section provenance, i.e. ref-
erence entries show first than in silico predicted entries;
and then, results are sorted by BLAST similarity score.
Hit alignment page
By clicking on an alignment description on the alignment
hits table (Figure 4), the system shows an in-depth visual
representation (amino acid by amino acid) of the alignment
(Figure 5). Moreover, the user has access to additional in-
formation about the matching peptide, such as sequence
length, bioactivity potential (potential or experimentally
validated), molecular weight and isoelectric point. In
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addition to these data, MAHMI records are compliant
with the Minimum information about any (x) sequence
(MIxS) checklist for metagenomes (34). Whenever avail-
able, source proteins are cross-linked to external database
records, namely, UniProt (33), CancerPPD (27),
VaxinPAD (26) and Metahit metagenome records.
Results download
All search results, namely the BLASTP alignments, the pep-
tide sequences and all figures can be downloaded.
Specifically, the user can obtain the BLASTP output file
(default format) as well as the hits distribution component
as image (PNG format). The alignment table can be ex-
ported as image (PNG format) or plain text file (CSV for-
mat). On the alignment information page, the detailed
alignment figure can be downloaded as PNG image. The
user can also download additional peptide information,
namely, sequence and possible sources, whenever available.
Public REST API
In addition to the graphical user interface, MAHMI pro-
vides a public REST API to download all data relating to
Figure 2. Snapshot of the advanced search. The query sequence is ‘LASDPIVLSKPDYGWANNHTFV’ and both data sections are searched, with the fol-
lowing custom BLAST options: threshold set to 3, window size set to 3, word size set to 2, gap extend set to 2, gap open set to 9 and ungapped search
selected.
Database, Vol. 2017, Article ID baw157 Page 5 of 10
Figure 3. Snapshot of the hit distribution of results for a query search. The query sequence is ‘LASDPIVLSKPDYGWANNHTFV’ and both data sections
are searched, with the following custom BLAST options: threshold set to 3, window size set to 3, word size set to 2, gap extend set to 2, gap open set
to 9 and ungapped search selected. Returned hits are presented in the same order as they appear in the BLAST file. Also, hits are coloured based on
the assigned bit score.
Figure 4. Snapshot of the table detailing the hits of a query search. This table gathers together all BLAST hits and their attributes (bit score, expected
value, identities, positives and gaps). Clicking on one hit, it redirects the user to the alignment information of this hit.
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Figure 5. Snapshot of the hit alignment information. Properties table includes the high-scoring pair attributes of the hit, bioactivity (potential bioactiv-
ity, in the case of in silico predictions), molecular weight and isoelectric point. Source proteins are cross-linked to UniProt and Metahit metagenome
entries. The alignment figure compares in more depth (amino acid by amino acid) the alignment of the proposed hit with the query sequence.
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proteins and peptides in the database. The main methods
provided by this API are listed below:
• GET/peptides/reference, which returns the reference
peptides;
• GET/peptides that returns the bioactive peptides;
• POST/peptides/search þ search XML object (see details
in Supplementary material 1), which enables batch
searches, similar to those that can be performed on the
web;
• GET/peptides/sourceProteins/$peptide_id, which returns
information about a given peptide, namely the list of
source proteins (cross-referenced to Uniprot) and meta-
genome information, namely MIxS compliant data;
• GET/proteins/$peptide_id, which returns the proteins
that produce a specific peptide.
This API is publicly available at http://mahmi.org/api.
Database utility
To the best of our knowledge, and with the exception of
VaxinPAD and CancerPPD, no effort has been conducted
to extensively collect data on peptides encrypted in the pro-
tein complement of the human microbiome with immuno-
modulatory and antiproliferative potential bioactivities.
This prompted us to create MAHMI, an online and access-
ible resource containing massive information on potential
bioactive peptides. Sequences contained within MAHMI
database may help the basic researcher working in the field
of bacteria-human host molecular cross-talk, as this kind
of peptides are relevant from a physiological and immune
point of view.
Proteins produced by our intestinal microbiota are
important molecular targets that can allow the study of
the mechanism of action of our gut microbes (35).
Notably, surface proteins are key extracellular components
in the mediation of certain interactions, such as immuno-
modulation or mucosal colonization (5). A subset of these
proteins, the secreted proteins, may even be able to inter-
act directly with mucosal cells once released by the
microorganism to their surrounding environment (36).
Extracellular proteins from the gut microbiota are either
cleaved by GIT proteases or processed by professional anti-
gen presenting cells such as dendritic cells (37). This inter-
action mediated by peptides produced by the digestion of
our gut microbe proteins ends in physiological changes of
the cell (38), including signalling pathway regulation,
changes in the secretion of chemokins, cytokines and
anti-bactericidal peptides (defensines), mucus secretion,
production of pseudopods by dendritic cells (DCs),
rearrangement of the tight-junctions in epithelial cells, and
modulation of the immune function and the response of
the gut-associated lymphoid tissue (GALT) cells (39).
This is a very promising field and, for instance, recent
results have revealed that a peptide encrypted in a
Lactobacillus plantarum extracellular protein, more con-
cisely an aggregation factor, is able to modulate the im-
mune status of both intestinal and monocyte-differentiated
DCs, including cytokine secretion and toll-like receptors
(TLR) expression (40, 41). By querying the content of
MAHMI database, the researcher will easily have insights
about the potential bioactivity of the user-submitted amino
acid sequence.
Conclusions
MAHMI database offers a novel and comprehensive re-
pository about peptides with immunomodulatory and anti-
proliferative potential. MAHMI has the potential to aid in
the study of how to balance altered immune responses and,
ideally, in the innovative development of new functional
ingredients or drugs based on bioactive peptides obtained
from the genetic sequences of the human microbiome.
These may be directed to the prevention of several gastro-
intestinal disorders of autoimmune and inflammatory na-
ture as well as the minimisation of the effects of the disease
in patients.
Availability and requirement
The Mechanism of Action of the Human Microbiome
(MAHMI) database is freely accessible for research pur-
poses for non-profit and academic organisations at http://
mahmi.org/.
Supplementary data
Supplementary data are available at Database Online.
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